ID H2BFS_HUMAN Reviewed; 126 AA. AC P57053; A0AVF9; Q5R2W0; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 27-MAR-2024, entry version 196. DE RecName: Full=Histone H2B type F-S {ECO:0000305}; DE AltName: Full=H2B-clustered histone 12 like {ECO:0000312|HGNC:HGNC:4762}; DE AltName: Full=H2B.S histone 1 {ECO:0000312|HGNC:HGNC:4762}; DE AltName: Full=Histone H2B.s; DE Short=H2B/s; GN Name=H2BC12L {ECO:0000312|HGNC:HGNC:4762}; GN Synonyms=H2BFS {ECO:0000312|HGNC:HGNC:4762}, H2BS1 GN {ECO:0000312|HGNC:HGNC:4762}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Shimizu N., Kudoh J., Shibuya K.; RT "Genomic structure of putative H2B histone family protein gene."; RL Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=10830953; DOI=10.1038/35012518; RA Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., RA Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M., RA Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U., RA Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A., RA Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J., RA Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K., RA Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G., RA Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J., RA Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S., RA Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K., RA Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.; RT "The DNA sequence of human chromosome 21."; RL Nature 405:311-319(2000). RN [3] RP PROTEIN SEQUENCE OF 2-21, AND FUNCTION. RX PubMed=11859126; DOI=10.4049/jimmunol.168.5.2356; RA Kim H.S., Cho J.H., Park H.W., Yoon H., Kim M.S., Kim S.C.; RT "Endotoxin-neutralizing antimicrobial proteins of the human placenta."; RL J. Immunol. 168:2356-2364(2002). RN [4] RP PROTEIN SEQUENCE OF 2-13. RX PubMed=8620898; DOI=10.1111/j.1432-1033.1996.0086n.x; RA Frohm M., Gunne H., Bergman A.-C., Agerberth B., Bergman T., Boman A., RA Liden S., Joernvall H., Boman H.G.; RT "Biochemical and antibacterial analysis of human wound and blister fluid."; RL Eur. J. Biochem. 237:86-92(1996). RN [5] RP PROTEIN SEQUENCE OF 2-13, AND FUNCTION. RX PubMed=12860195; DOI=10.1016/s0196-9781(03)00114-1; RA Tollin M., Bergman P., Svenberg T., Joernvall H., Gudmundsson G.H., RA Agerberth B.; RT "Antimicrobial peptides in the first line defence of human colon mucosa."; RL Peptides 24:523-530(2003). RN [6] RP PROTEIN SEQUENCE OF 2-13, AND FUNCTION. RX PubMed=15019208; DOI=10.1016/j.peptides.2003.07.028; RA Howell S.J., Wilk D., Yadav S.P., Bevins C.L.; RT "Antimicrobial polypeptides of the human colonic epithelium."; RL Peptides 24:1763-1770(2003). RN [7] RP PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; RP LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109, RP UBIQUITINATION AT LYS-121, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=16627869; DOI=10.1074/mcp.m600007-mcp200; RA Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P., RA Grauslund M., Hansen A.M., Jensen O.N.; RT "Quantitative proteomic analysis of post-translational modifications of RT human histones."; RL Mol. Cell. Proteomics 5:1314-1325(2006). RN [8] RP PHOSPHORYLATION AT SER-15. RX PubMed=12757711; DOI=10.1016/s0092-8674(03)00355-6; RA Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A., RA Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.; RT "Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile RT twenty kinase."; RL Cell 113:507-517(2003). RN [9] RP UBIQUITINATION AT LYS-121. RX PubMed=16307923; DOI=10.1016/j.molcel.2005.09.025; RA Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H., Tempst P., RA Reinberg D.; RT "Monoubiquitination of human histone H2B: the factors involved and their RT roles in HOX gene regulation."; RL Mol. Cell 20:601-611(2005). RN [10] RP ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21. RX PubMed=16283522; DOI=10.1007/s11010-005-8285-1; RA Golebiowski F., Kasprzak K.S.; RT "Inhibition of core histones acetylation by carcinogenic nickel(II)."; RL Mol. Cell. Biochem. 279:133-139(2005). RN [11] RP UBIQUITINATION AT LYS-121. RX PubMed=16713563; DOI=10.1016/j.cell.2006.04.029; RA Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D.; RT "Histone H2B monoubiquitination functions cooperatively with FACT to RT regulate elongation by RNA polymerase II."; RL Cell 125:703-717(2006). RN [12] RP CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24 AND RP LYS-35. RX PubMed=21925322; DOI=10.1016/j.cell.2011.08.008; RA Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., RA Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q., Wysocka J., RA Ye Y., Khochbin S., Ren B., Zhao Y.; RT "Identification of 67 histone marks and histone lysine crotonylation as a RT new type of histone modification."; RL Cell 146:1016-1028(2011). RN [13] RP UBIQUITINATION AT LYS-35. RX PubMed=21726816; DOI=10.1016/j.molcel.2011.05.015; RA Wu L., Zee B.M., Wang Y., Garcia B.A., Dou Y.; RT "The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase RT for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation."; RL Mol. Cell 43:132-144(2011). RN [14] RP SUCCINYLATION AT LYS-35; LYS-117 AND LYS-121, AND MALONYLATION AT LYS-117. RX PubMed=22389435; DOI=10.1074/mcp.m111.015875; RA Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.; RT "Lysine succinylation and lysine malonylation in histones."; RL Mol. Cell. Proteomics 11:100-107(2012). RN [15] RP UBIQUITINATION, AND DEUBIQUITINATION BY USP49. RX PubMed=23824326; DOI=10.1101/gad.211037.112; RA Zhang Z., Jones A., Joo H.Y., Zhou D., Cao Y., Chen S., RA Erdjument-Bromage H., Renfrow M., He H., Tempst P., Townes T.M., RA Giles K.E., Ma L., Wang H.; RT "USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA RT splicing."; RL Genes Dev. 27:1581-1595(2013). RN [16] RP HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35; RP LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121. RX PubMed=24681537; DOI=10.1038/nchembio.1497; RA Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H., Debernardi A., RA Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z., Allis C.D., Ren B., RA Khochbin S., Zhao Y.; RT "Lysine 2-hydroxyisobutyrylation is a widely distributed active histone RT mark."; RL Nat. Chem. Biol. 10:365-370(2014). RN [17] RP BUTYRYLATION AT LYS-6 AND LYS-21. RX PubMed=27105113; DOI=10.1016/j.molcel.2016.03.014; RA Goudarzi A., Zhang D., Huang H., Barral S., Kwon O.K., Qi S., Tang Z., RA Buchou T., Vitte A.L., He T., Cheng Z., Montellier E., Gaucher J., RA Curtet S., Debernardi A., Charbonnier G., Puthier D., Petosa C., Panne D., RA Rousseaux S., Roeder R.G., Zhao Y., Khochbin S.; RT "Dynamic competing histone H4 K5K8 acetylation and butyrylation are RT hallmarks of highly active gene promoters."; RL Mol. Cell 62:169-180(2016). RN [18] RP HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-17; LYS-21; LYS-35; LYS-86; RP LYS-117 AND LYS-121. RX PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036; RA Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J., RA Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D., RA Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B., RA White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.; RT "Metabolic regulation of gene expression by histone lysine beta- RT hydroxybutyrylation."; RL Mol. Cell 62:194-206(2016). RN [19] RP ADP-RIBOSYLATION AT GLU-3. RX PubMed=27530147; DOI=10.1038/ncomms12404; RA Grundy G.J., Polo L.M., Zeng Z., Rulten S.L., Hoch N.C., Paomephan P., RA Xu Y., Sweet S.M., Thorne A.W., Oliver A.W., Matthews S.J., Pearl L.H., RA Caldecott K.W.; RT "PARP3 is a sensor of nicked nucleosomes and monoribosylates histone RT H2B(Glu2)."; RL Nat. Commun. 7:12404-12404(2016). RN [20] RP GLUTARYLATION AT LYS-17; LYS-35; LYS-44; LYS-47; LYS-109; LYS-117 AND RP LYS-121. RX PubMed=31542297; DOI=10.1016/j.molcel.2019.08.018; RA Bao X., Liu Z., Zhang W., Gladysz K., Fung Y.M.E., Tian G., Xiong Y., RA Wong J.W.H., Yuen K.W.Y., Li X.D.; RT "Glutarylation of histone H4 lysine 91 regulates chromatin dynamics."; RL Mol. Cell 0:0-0(2019). RN [21] RP LACTYLATION AT LYS-6; LYS-12; LYS-16; LYS-17; LYS-21; LYS-24; LYS-44; RP LYS-86; LYS-109; LYS-117 AND LYS-121. RX PubMed=31645732; DOI=10.1038/s41586-019-1678-1; RA Zhang D., Tang Z., Huang H., Zhou G., Cui C., Weng Y., Liu W., Kim S., RA Lee S., Perez-Neut M., Ding J., Czyz D., Hu R., Ye Z., He M., Zheng Y.G., RA Shuman H.A., Dai L., Ren B., Roeder R.G., Becker L., Zhao Y.; RT "Metabolic regulation of gene expression by histone lactylation."; RL Nature 574:575-580(2019). RN [22] RP ADP-RIBOSYLATION AT SER-7. RX PubMed=34874266; DOI=10.7554/elife.71502; RA Mohapatra J., Tashiro K., Beckner R.L., Sierra J., Kilgore J.A., RA Williams N.S., Liszczak G.; RT "Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin RT remodeling."; RL Elife 10:0-0(2021). CC -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact CC DNA into chromatin, limiting DNA accessibility to the cellular CC machineries which require DNA as a template. Histones thereby play a CC central role in transcription regulation, DNA repair, DNA replication CC and chromosomal stability. DNA accessibility is regulated via a complex CC set of post-translational modifications of histones, also called CC histone code, and nucleosome remodeling. CC -!- FUNCTION: Has broad antibacterial activity. May contribute to the CC formation of the functional antimicrobial barrier of the colonic CC epithelium, and to the bactericidal activity of amniotic fluid. CC -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules CC each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and CC two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of CC DNA. CC -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. CC -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2 dimer is CC required for histone H3 'Lys-4' (H3K4me) and 'Lys-79' (H3K79me) CC methylation and transcription activation at specific gene loci, such as CC HOXA9 and MEIS1 loci. Similarly, monoubiquitination at Lys-121 CC (H2BK120Ub) by the RNF20/40 complex gives a specific tag for epigenetic CC transcriptional activation and is also prerequisite for histone H3 CC 'Lys-4' and 'Lys-79' methylation. It also functions cooperatively with CC the FACT dimer to stimulate elongation by RNA polymerase II. H2BK120Ub CC also acts as a regulator of mRNA splicing: deubiquitination by USP49 is CC required for efficient cotranscriptional splicing of a large set of CC exons. {ECO:0000269|PubMed:16627869}. CC -!- PTM: Phosphorylation at Ser-37 (H2BS36ph) by AMPK in response to stress CC promotes transcription (By similarity). Phosphorylated on Ser-15 CC (H2BS14ph) by STK4/MST1 during apoptosis; which facilitates apoptotic CC chromatin condensation (PubMed:12757711). Also phosphorylated on Ser-15 CC in response to DNA double strand breaks (DSBs), and in correlation with CC somatic hypermutation and immunoglobulin class-switch recombination. CC {ECO:0000250|UniProtKB:Q64475, ECO:0000269|PubMed:12757711}. CC -!- PTM: GlcNAcylation at Ser-113 promotes monoubiquitination of Lys-121. CC It fluctuates in response to extracellular glucose, and associates with CC transcribed genes (By similarity). {ECO:0000250|UniProtKB:P62807}. CC -!- PTM: ADP-ribosylated by PARP1 or PARP2 on Ser-7 (H2BS6ADPr) in response CC to DNA damage (PubMed:34874266). H2BS6ADPr promotes recruitment of CC CHD1L (PubMed:34874266). Mono-ADP-ribosylated on Glu-3 (H2BE2ADPr) by CC PARP3 in response to single-strand breaks (PubMed:27530147). Poly ADP- CC ribosylation on Glu-36 (H2BE35ADPr) by PARP1 regulates adipogenesis: it CC inhibits phosphorylation at Ser-37 (H2BS36ph), thereby blocking CC expression of pro-adipogenetic genes (By similarity). CC {ECO:0000250|UniProtKB:Q6ZWY9, ECO:0000269|PubMed:27530147, CC ECO:0000269|PubMed:34874266}. CC -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and CC marks testis-specific genes in post-meiotic cells, including X-linked CC genes that escape sex chromosome inactivation in haploid cells. CC Crotonylation marks active promoters and enhancers and confers CC resistance to transcriptional repressors. It is also associated with CC post-meiotically activated genes on autosomes. CC {ECO:0000269|PubMed:21925322}. CC -!- PTM: Lactylated in macrophages by EP300/P300 by using lactoyl-CoA CC directly derived from endogenous or exogenous lactate, leading to CC stimulates gene transcription. {ECO:0000269|PubMed:31645732}. CC -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB041017; BAD74065.1; -; Genomic_DNA. DR EMBL; AP001751; BAA95538.1; -; Genomic_DNA. DR PIR; S65409; S65409. DR RefSeq; XP_006723981.1; XM_006723918.3. DR AlphaFoldDB; P57053; -. DR SMR; P57053; -. DR BioGRID; 3195446; 79. DR IntAct; P57053; 76. DR STRING; 9606.ENSP00000481622; -. DR GlyCosmos; P57053; 1 site, No reported glycans. DR GlyGen; P57053; 1 site. DR iPTMnet; P57053; -. DR MetOSite; P57053; -. DR PhosphoSitePlus; P57053; -. DR SwissPalm; P57053; -. DR BioMuta; H2BFS; -. DR DMDM; 9973351; -. DR EPD; P57053; -. DR jPOST; P57053; -. DR MassIVE; P57053; -. DR MaxQB; P57053; -. DR PaxDb; 9606-ENSP00000481622; -. DR PeptideAtlas; P57053; -. DR ProteomicsDB; 56969; -. DR Pumba; P57053; -. DR TopDownProteomics; P57053; -. DR Antibodypedia; 74258; 148 antibodies from 14 providers. DR Ensembl; ENST00000599962.2; ENSP00000481622.1; ENSG00000234289.6. DR GeneID; 102724334; -. DR KEGG; hsa:102724334; -. DR MANE-Select; ENST00000599962.2; ENSP00000481622.1; NM_017445.3; NP_059141.1. DR UCSC; uc002zdj.2; human. DR AGR; HGNC:4762; -. DR DisGeNET; 102724334; -. DR GeneCards; H2BC12L; -. DR HGNC; HGNC:4762; H2BC12L. DR HPA; ENSG00000234289; Low tissue specificity. DR neXtProt; NX_P57053; -. DR OpenTargets; ENSG00000234289; -. DR VEuPathDB; HostDB:ENSG00000234289; -. DR eggNOG; KOG1744; Eukaryota. DR GeneTree; ENSGT01100000263506; -. DR HOGENOM; CLU_075666_2_1_1; -. DR InParanoid; P57053; -. DR OrthoDB; 5261598at2759; -. DR PathwayCommons; P57053; -. DR Reactome; R-HSA-110328; Recognition and association of DNA glycosylase with site containing an affected pyrimidine. DR Reactome; R-HSA-110329; Cleavage of the damaged pyrimidine. DR Reactome; R-HSA-110330; Recognition and association of DNA glycosylase with site containing an affected purine. DR Reactome; R-HSA-110331; Cleavage of the damaged purine. DR Reactome; R-HSA-1221632; Meiotic synapsis. DR Reactome; R-HSA-171306; Packaging Of Telomere Ends. DR Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation. DR Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex. DR Reactome; R-HSA-212300; PRC2 methylates histones and DNA. DR Reactome; R-HSA-2299718; Condensation of Prophase Chromosomes. DR Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence. DR Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP). DR Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence. DR Reactome; R-HSA-427359; SIRT1 negatively regulates rRNA expression. DR Reactome; R-HSA-427389; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression. DR Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression. DR Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression. DR Reactome; R-HSA-5334118; DNA methylation. DR Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs. DR Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis. DR Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3. DR Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks. DR Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ). DR Reactome; R-HSA-5693607; Processing of DNA double-strand break ends. DR Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere. DR Reactome; R-HSA-68616; Assembly of the ORC complex at the origin of replication. DR Reactome; R-HSA-69473; G2/M DNA damage checkpoint. DR Reactome; R-HSA-73728; RNA Polymerase I Promoter Opening. DR Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape. DR Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function. DR Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs. DR Reactome; R-HSA-9018519; Estrogen-dependent gene expression. DR Reactome; R-HSA-912446; Meiotic recombination. DR Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis. DR Reactome; R-HSA-9670095; Inhibition of DNA recombination at telomere. DR Reactome; R-HSA-9710421; Defective pyroptosis. DR Reactome; R-HSA-977225; Amyloid fiber formation. DR Reactome; R-HSA-9821002; Chromatin modifications during the maternal to zygotic transition (MZT). DR Reactome; R-HSA-9821993; Replacement of protamines by nucleosomes in the male pronucleus. DR SignaLink; P57053; -. DR SIGNOR; P57053; -. DR BioGRID-ORCS; 102724334; 0 hits in 6 CRISPR screens. DR Pharos; P57053; Tbio. DR PRO; PR:P57053; -. DR Proteomes; UP000005640; Chromosome 21. DR RNAct; P57053; Protein. DR Bgee; ENSG00000234289; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 19 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005615; C:extracellular space; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW. DR GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro. DR GO; GO:0030527; F:structural constituent of chromatin; IEA:InterPro. DR GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB. DR GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB. DR GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB. DR GO; GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB. DR GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB. DR Gene3D; 1.10.20.10; Histone, subunit A; 1. DR InterPro; IPR009072; Histone-fold. DR InterPro; IPR007125; Histone_H2A/H2B/H3. DR InterPro; IPR000558; Histone_H2B. DR PANTHER; PTHR23428; HISTONE H2B; 1. DR PANTHER; PTHR23428:SF382; HISTONE H2B TYPE 1-K-RELATED; 1. DR Pfam; PF00125; Histone; 1. DR PRINTS; PR00621; HISTONEH2B. DR SMART; SM00427; H2B; 1. DR SUPFAM; SSF47113; Histone-fold; 1. DR PROSITE; PS00357; HISTONE_H2B; 1. DR Genevisible; P57053; HS. PE 1: Evidence at protein level; KW Acetylation; ADP-ribosylation; Antibiotic; Antimicrobial; Chromosome; KW Direct protein sequencing; DNA-binding; Glycoprotein; Hydroxylation; KW Isopeptide bond; Methylation; Nucleosome core; Nucleus; Phosphoprotein; KW Reference proteome; Ubl conjugation. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P23527, FT ECO:0000269|PubMed:11859126, ECO:0000269|PubMed:12860195, FT ECO:0000269|PubMed:15019208, ECO:0000269|PubMed:8620898" FT CHAIN 2..126 FT /note="Histone H2B type F-S" FT /id="PRO_0000071838" FT REGION 1..36 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 17..35 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 2 FT /note="N-acetylproline" FT /evidence="ECO:0000250|UniProtKB:P23527" FT MOD_RES 3 FT /note="ADP-ribosyl glutamic acid" FT /evidence="ECO:0000269|PubMed:27530147" FT MOD_RES 6 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 6 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 6 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16283522, FT ECO:0000269|PubMed:16627869" FT MOD_RES 6 FT /note="N6-butyryllysine; alternate" FT /evidence="ECO:0000269|PubMed:27105113" FT MOD_RES 6 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 6 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 7 FT /note="ADP-ribosylserine" FT /evidence="ECO:0000269|PubMed:34874266" FT MOD_RES 12 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 12 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16627869" FT MOD_RES 12 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 12 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 13 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 13 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16283522, FT ECO:0000269|PubMed:16627869" FT MOD_RES 13 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 15 FT /note="Phosphoserine; by STK4/MST1" FT /evidence="ECO:0000269|PubMed:12757711" FT MOD_RES 16 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16283522, FT ECO:0000269|PubMed:16627869" FT MOD_RES 16 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 16 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 17 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 17 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16627869" FT MOD_RES 17 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 17 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 17 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 21 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 21 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 21 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16283522, FT ECO:0000269|PubMed:16627869" FT MOD_RES 21 FT /note="N6-butyryllysine; alternate" FT /evidence="ECO:0000269|PubMed:27105113" FT MOD_RES 21 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 21 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 24 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 24 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P33778" FT MOD_RES 24 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 24 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 25 FT /note="N6-(2-hydroxyisobutyryl)lysine" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 35 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 35 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 35 FT /note="N6-crotonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:21925322" FT MOD_RES 35 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 35 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000269|PubMed:22389435" FT MOD_RES 36 FT /note="PolyADP-ribosyl glutamic acid" FT /evidence="ECO:0000250|UniProtKB:Q64475" FT MOD_RES 37 FT /note="Phosphoserine; by AMPK" FT /evidence="ECO:0000250|UniProtKB:Q64475" FT MOD_RES 44 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 44 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 44 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 47 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 47 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 47 FT /note="N6-methyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16627869" FT MOD_RES 58 FT /note="N6,N6-dimethyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16627869" FT MOD_RES 58 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 80 FT /note="Dimethylated arginine" FT /evidence="ECO:0000250|UniProtKB:Q96A08" FT MOD_RES 86 FT /note="N6,N6,N6-trimethyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:Q96A08" FT MOD_RES 86 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 86 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 86 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:Q96A08" FT MOD_RES 86 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 87 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000250|UniProtKB:Q96A08" FT MOD_RES 93 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000250|UniProtKB:Q96A08" FT MOD_RES 109 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 109 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 109 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 109 FT /note="N6-methyllysine; alternate" FT /evidence="ECO:0000269|PubMed:16627869" FT MOD_RES 116 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q00729" FT MOD_RES 117 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 117 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 117 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 117 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 117 FT /note="N6-malonyllysine; alternate" FT /evidence="ECO:0000269|PubMed:22389435" FT MOD_RES 117 FT /note="N6-methylated lysine; alternate" FT /evidence="ECO:0000250|UniProtKB:Q00729" FT MOD_RES 117 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000269|PubMed:22389435" FT MOD_RES 121 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:24681537" FT MOD_RES 121 FT /note="N6-(beta-hydroxybutyryl)lysine; alternate" FT /evidence="ECO:0000269|PubMed:27105115" FT MOD_RES 121 FT /note="N6-glutaryllysine; alternate" FT /evidence="ECO:0000269|PubMed:31542297" FT MOD_RES 121 FT /note="N6-lactoyllysine; alternate" FT /evidence="ECO:0000269|PubMed:31645732" FT MOD_RES 121 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000269|PubMed:22389435" FT CARBOHYD 113 FT /note="O-linked (GlcNAc) serine" FT /evidence="ECO:0000250|UniProtKB:P62807" FT CROSSLNK 6 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:P58876" FT CROSSLNK 21 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:Q5QNW6" FT CROSSLNK 35 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in ubiquitin); alternate" FT /evidence="ECO:0000269|PubMed:21726816" FT CROSSLNK 121 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in ubiquitin); alternate" FT /evidence="ECO:0000269|PubMed:16307923, FT ECO:0000269|PubMed:16627869, ECO:0000269|PubMed:16713563" SQ SEQUENCE 126 AA; 13944 MW; 8B1431CB76B9005E CRC64; MPEPAKSAPA PKKGSKKAVT KAQKKDGRKR KRSRKESYSV YVYKVLKQVH PDTGISSKAM GIMNSFVNDI FERIAGEASR LPHYNKRSTI TSREIQTAVR LLLPGELAKH AVSEGTKAVT KYTSAK //